Core Stability Training in Multiple Sclerosis

Sponsor
University of Plymouth (Other)
Overall Status
Completed
CT.gov ID
NCT01414725
Collaborator
(none)
100
7
3
23
14.3
0.6

Study Details

Study Description

Brief Summary

The primary purpose of this study is to determine whether a 12 week Pilates based core stability training programme is effective in improving balance, mobility and balance confidence in ambulant individuals with Multiple Sclerosis (MS).

Condition or Disease Intervention/Treatment Phase
  • Other: Standard Physiotherapy Exercises
  • Other: Core Stability Training
  • Other: Relaxation
N/A

Detailed Description

The primary purpose of this study is to determine whether a 12 week Pilates based core stability training programme is effective in improving balance, mobility and balance confidence in ambulant individuals with Multiple Sclerosis (MS). The secondary aim is to determine the relative effectiveness of this 12 week Pilates based core stability training programme compared to a standardised physiotherapy exercise programme. Finally we intend to explore the underlying mechanisms of change associated with these exercise interventions by directly measuring changes in muscle thickness and activation in the deep abdominal core stabilising muscles of a sub-set of participants.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Core Stability Training in Ambulant Individuals With Multiple Sclerosis: a Multi-centre Randomised Controlled Trial.
Study Start Date :
Aug 1, 2011
Actual Primary Completion Date :
Jul 1, 2013
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Core Stability Training

Other: Core Stability Training
Individualised face to face training sessions, delivered over 12 weeks, plus an individualised 15-minute daily home exercise programme will be provided. This will be undertaken by a neurological physiotherapist with experience in the delivery of core stability training to people with MS. Exercises will be progressed in response to the abilities of the individual. Each participant will receive a workbook with written and diagrammatic instructions describing their home exercise programme.
Other Names:
  • Physiotherapy
  • Placebo Comparator: Relaxation

    Other: Relaxation
    Three face to face individualised relaxation sessions, provided at 4 weekly intervals, plus a 15-minute home programme based around an audio relaxation CD. Weekly telephone contact / support will be provided.
    Other Names:
  • Physiotherapy
  • Active Comparator: Standard Physiotherapy Exercises

    Other: Standard Physiotherapy Exercises
    Individualised face to face training sessions, delivered over 12 weeks, plus an individualised 15-minute daily home exercise programme will be provided. This will be undertaken by a neurological physiotherapist. The exercises will comprise a standardised programme of simple physiotherapy exercises which aim to improve trunk and pelvic stability, lower limb muscle length and strength, and balance and control of movement, as described by Barrett et al [2009]. Exercises will be progressed in response to the abilities of the individual. Each participant will receive a workbook with written and diagrammatic instructions describing their home exercise programme.
    Other Names:
  • Physiotherapy
  • Outcome Measures

    Primary Outcome Measures

    1. Change in 10 metre timed walk (10MTW) [baseline (pre intervention), 12 weeks (immediately post intervention), 16 weeks ( one month follow-up)]

    Secondary Outcome Measures

    1. Change in Functional Reach - forwards and lateral [baseline (pre intervention), 12 weeks (immediately post intervention), 16 weeks ( one month follow-up)]

    2. Change in Visual Analogue Scale (10 point) to determine "Difficulty in carrying a drink when walking". [baseline (pre intervention), 12 weeks (immediately post intervention), 16 weeks ( one month follow-up)]

    3. Change in Activities-specific Balance Confidence (ABC) Scale [baseline (pre intervention), 12 weeks (immediately post intervention), 16 weeks (one month follow-up)]

    4. Change in Multiple Sclerosis 12-item Walking Scale [baseline (pre intervention), 12 weeks (immediately post intervention), 16 weeks (one month follow-up)]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Definite diagnosis of MS, according to McDonald's criteria

    • Aged 18 years or over

    • Able to walk independently with or without use of intermittent or constant unilateral assistance such as walking stick or orthotic brace

    Exclusion Criteria:
    • In relapse or relapse in previous three months

    • Any medical condition contra-indicating participation in core stability exercises

    • Score < 6 on the Abbreviated Mental Test, as an indicator of those whose cognitive difficulties could interfere with the informed consent process, or the ability to fully engage in the exercise programme.

    • Current or recent (within past 6 months) participation in core stability exercises

    • Current involvement in another interventional research study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Merlin Centre, Bradbury House, Hewas water St Austell Cornwall United Kingdom PL26 7JF
    2 Devon NHS Trust Newton Abbot Devon United Kingdom TQ12 2SL
    3 University Of Plymouth, School of Health Professions Plymouth Devon United Kingdom PL6 9BH
    4 Tavistock Community Hospital Spring Hill, Tavistock Devon United Kingdom PL19 8LD
    5 Lanarkshire NHS Trust Cumbernauld North Lanarkshire United Kingdom G671BP
    6 South Tees NHS Trust Middlesborough South Tees United Kingdom TS3BW
    7 University College London Hospital Trust London United Kingdom WC1 N3BG

    Sponsors and Collaborators

    • University of Plymouth

    Investigators

    • Principal Investigator: Jennifer Freeman, University of Plymouth

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jenny Freeman, Dr Jenny Freeman, University of Plymouth
    ClinicalTrials.gov Identifier:
    NCT01414725
    Other Study ID Numbers:
    • 10/H0106/88
    First Posted:
    Aug 11, 2011
    Last Update Posted:
    Mar 24, 2014
    Last Verified:
    Mar 1, 2014
    Keywords provided by Jenny Freeman, Dr Jenny Freeman, University of Plymouth
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 24, 2014